Abstract
PURPOSE: The aim of our study was to determine to what extent serial carcinoembryonic antigen (CEA) monitoring is helpful in detecting colorectal cancer recurrence in patients if their preoperative serum CEA is normal. Additional major objectives of this study were to correlate CEA immunohistochemical features of the primary tumor with serum CEA levels at the time of tumor recurrence in node-positive colorectal cancer patients with low preoperative CEA values. METHODS: One hundred fourteen node-positive colorectal cancer patients with preoperative serum CEA levels of <5.0 ng/ml undergoing clinically curative operations were studied. Primary tumors were evaluated for tissue CEA using the same monoclonal antibody as used for serum CEA determinations utilizing the avidin-biotin-peroxidase immunohistochemical technique. RESULTS: The exact preoperative serum CEA value did not correlate with tumor grade, immunohistochemical CEA intensity or pattern. In the 32 patients who developed recurrent cancer, the serum CEA at recurrence was greater than 5 ng/ml in 44 percent. All such patients had CEA present in their primary tumor. There was no correlation with the exact preoperative serum CEA, the intensity of the primary tissue CEA, or the localization of such CEA and subsequent serum elevation at recurrence. CONCLUSION: Serum CEA is a useful marker in the detection of recurrent colorectal cancer despite normal preoperative values.
Article PDF
Similar content being viewed by others
Avoid common mistakes on your manuscript.
References
Kohler JP, Simnonowitz D, Paloyan D. Pre-operative CEA level: a prognostic test in patients with colorectal carcinoma. Am Surg 1980;46:449–52.
Wolmark N, Fisher B, Wieaund HS. The prognostic value of modifications of Dukes' C class of colorectal cancer: an analysis of the NASBP clinical trials. Ann Surg 1986;203:115–22. significance of carcinoembryonic antigen in colorectal carcinoma, serum levels before and after resection and before recurrence. Arch Surg 1991;126: 314–6.
Martin EW Jr, Minton JP, Carey LC. CEA-directed second-look surgery in the asymptomatic patient after primary resection of colorectal cancer. Ann Surg 1985;202:310–17.
Goslin R, Steele G, MacIntyre J,et al. The use of pre-operative plasma CEA levels for the stratification of patients after curative resection of colorectal cancer. Ann Surg 1980;192:747–51.
Wanebo JH, Stearns MW, Schwartz MK. Use CEA as an indicator of early recurrence and as a guide to a selected second-look procedure in patients with colorectal cancer. Ann Surg 1978;188:481–92.
Goldenberg DM, Goldenberg H, Sharkey RM,et al. Imaging of colorectal carcinoma with radiolabeled antibodies. Semin Nucl Med 1989;19:262–81.
Zeng ZS, Divgi CR, McDermott KC,et al. Radioimmunodetection of colorectal cancer. Perspect Colon Rectal Surg 1991;4:35–67.
Lind P, Lechner P, Arian-Schad K,et al. Anti-carcinoembryonic antigen immunoscintigraphy (technetium-99 m-monoclonal antibody BW 431/26) and serum CEA levels in patients with suspected primary and recurrent colorectal carcinoma. J Nucl Med 1991;32:1319–25.
Gold P, Freeman SO. Specific carcinoembryonic antigens of the human digestive system. J Exp Med 1965;122:467–81.
Bordes M, Michiels R, Martin F. Detection by immunofluorescence of carcinoembryonic antigen in colonic carcinoma, other malignant or benign tumors and non-cancerous tissues. Digestion 1973;9:109–15.
Crowson M, Hockey MS, Newman J,et al. An immunocytochemical study of carcinoembryonic antigen (CEA) expression in colorectal tumors and their metastases using a monoclonal antibody (abstr). Br J Surg 1984;71:376.
Goldenberg DM, Sharkey RM, Primus FJ. Immunocytochemical detection of carcinoembryonic antigen in conventional histopathology specimens. Cancer 1978;42:1546–53.
Nakopoulou L, Zinozi M, Theodoropoulos G,et al. Carcinoembryonic antigen detection by immunocytochemical methods in carcinomas of the colon and stomach. Dis Colon Rectum 1983;26:269–74.
Midiri G, Amanti C, Benedetti M,et al. CEA tissue staining in colorectal cancer patients. Cancer 1985;55:2624–29.
Boyd CR, Bivens BA, Kashmire R,et al. Plasma CEA, tumor CEA, tumor histology. J Surg Oncol 1976;8:507–12.
Page M, Dalifard I, Bertrand G. Immunostaining of colorectal cancer with monoclonal anti-CEA antibodies compared to serum and tumor CEA content. Anticancer Res 1986;6:893–96.
Cunningham L, Stocking B, Halter SA,et al. Immunoperoxidase staining of carcinoembryonic antigen as a prognostic indicator in colorectal carcinoma. Dis Colon Rectum 1986;29:111–6.
Goslin R, O'brien MJ, Steele G,et al. Correlation of plasma CEA and CEA tissue staining in poorly differentiated colorectal cancer. Am J Med 1981;71:246–53.
Denk H, Tappeiner G, Eckerstorfer R,et al. Carcinoembryonic antigen in gastrointestinal and extragastrointestinal tumors and its relationship to tumor cell differentiation. Int J Cancer 1972;10:262–72.
Zamcheck N. The expanding field of colorectal cancer marker: CEA, the prototype. Cancer Bull 1981;33:141–51.
Hamada Y, Yamamura M, Hioki K,et al. Immuno-histochemical study of carcinoembryonic antigen in patients with colorectal cancer, correlation with plasma carcinoembryonic antigen levels. Cancer 1985;55:136–41.
Nagura H, Tsutsumi Y, Shioda Y,et al. Immunohistochemistry of gastric carcinoma and associated disease: novel distribution of carcinoembryonic antigen and secretory component on the surface of gastric cancer cells. J Histochem Cytochem 1992; 31(Suppl 1A):193–8.
Author information
Authors and Affiliations
About this article
Cite this article
Zeng, Z., Cohen, A.M. & Urmacher, C. Usefulness of carcinoembryonic antigen monitoring despite normal preoperative values in node-positive colon cancer patients. Dis Colon Rectum 36, 1063–1068 (1993). https://doi.org/10.1007/BF02047301
Issue Date:
DOI: https://doi.org/10.1007/BF02047301